VIRUS EPSTEIN-BARR (VEB) Y NEOPLASIA

C. Bellas, A. Santón, G. Plaza.

Laboratorio de Patología Molecular. Hospital Ramón y Cajal.

 

BIBLIOGRAFIA

  1. Anagnostopoulos I, Hummel M. Epstein-Barr virus in tumours. Histopathology 1996, 29: 297-315.
  2. Bellas C, Santón A, Manzanal A, Campo E, Martín C, Acevedo A, Varona C, Forteza J, Morente M, Montalbán C. Pathological, immunological, and molecular features of Hodgkin’s disease associated with HIV infection: comparison with ordinary Hodgkin’s disease. Am J Surg Pathol 1996; 20: 1520-1524.
  3. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt´s lymphoma. Lancet 1964; i: 702-703.
  4. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988; 42: 329-338.
  5. Gulley ML, Raab-Traub N. Detection of Epstein-Barr virus in human tissues by molecular genetic techniques. Arch Pathol Lab Med 1993; 117: 1115-1120.
  6. Hamilton-Dutoit SJ, Pallesen G. Detection of Epstein-Barr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridation. Histopathology 1994; 25: 101-111.
  7. Hu L-F, Chen F, Zhen Q-F, Zhang Y-W, Luo Y, Zheng X, Winberg G, Ernberg I, Klein G. Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinoma. Eur J Cancer 1995; 31A: 658-660.
  8. Hu L-F, Zabarovsky ER, Chen F, Cao S-L, Ernberg I, Klein G, Winberg G. Isolation and sequenting of the Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991; 72: 2399-2409.
  9. Hummel M Anagnostopoulos I, Korbjuhn P et al. Epstein-Barr virus in B-cell non-Hodgkin’s lymphomas :unexpected infection patterns and different infection incidence in low and high-grade types. J Pathol 1995; 175: 263-271.
  10. Iezzoni JC, Gaffey MJ, Weiss LM. The role of Epstein-Barr virus in lymphoepitelioma-like carcinomas. Am J Clin Pathol 1995; 103: 308-315.
  11. Isom HC, Wigdahl B, Howett MK. Molecular pathology of human oncogenic viruses: Epstein-Barr virus. En: Sirica E, ed. Cellular and molecular pathologenesis. 1º ed. Philadelphia. Lippincott-Raven Publishers, 1996, pp 341-356.
  12. Jiwa NM, Oudejans JJ, Bai MC et al. Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin’s disease: Implications of different pathogenic mechanism. Histopathology 1995, 26: 547-553.
  13. Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1991; 90: 9150-154.
  14. Kieff E. Epstein-Barr virus-increasing evidence of a link to carcinoma (editorial). N Engl J Med 1995; 333: 724-726.
  15. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlation with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996; 88: 242-251.
  16. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt BF, Delsol G, Pallesen G. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin´s disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937-2942.
  17. Knecht H, Bachmann E, Joske DJL, Sahli R, Emèry-Goodman A, Casanova J, Zilic M, Bachmann Z, Odermatt BF. Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin´s disease. Leukemia 1993; 7: 580-585.
  18. Lin C-T, Lin C-R, Tan G-K, Chen W, Dee AN, Chan W-Y. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells. Am J Pathol 1997; 150: 1745-1756.
  19. Niedobitek G, Hansmann Ml, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I, Friedrich R, Lobeck H, Sam CK, Araujo I, Rickinson AB, Stein H. Epstein-Barr virus and carcinomas: undiiferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991; 165: 17-24.
  20. Oudejans J. (1996) Epstein-Barr virus in the pathogenesis of lymphoproliferative disorders. Doctoral Thesis, Vrije Universiteit, Amsterdam.
  21. Oudejans JJ, Jiwa NM, van den Brule AJC et al. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual posttransplantation lymphoproliferative disorders. Am J Pathol 1995, 147: 923-933
  22. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Clonal proliferation of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995; 333: 693-698.
  23. Plaza G. (1997) Estudio clínico-morfológico del carcinoma nasofaríngeo. Análisis inmunohistoquímico y molecular de su relación con el virus de Epstein-Barr. Tesis Doctoral. Universidad de Alcalá. Madrid.
  24. Sam CK, Brooks LA, Niedobitek G, et al. Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. Int J Cancer 1993, 53: 957-962.
  25. Sandberg M, Hammerschmidt W, Sugden B. Characterization of LMP-1’s association with TRAF1, TRAF2 and TRAF3. J Virol 1997; 71: 4649-4656.
  26. Sandvej K, Peh S, Andresen BS, Pallesen G. Identification of potential hot spots in the carboxy-terminal part od the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphoma. Blood 1994; 84: 4053-4060.
  27. Santón A. (1997) Análisis molecular del omcogén LMP-1 del virus de Epstein-Barr en la enfermedad de Hodgkin. Tesis Doctoral. Universidad Complutense. Madrid.
  28. Thorley-Lawson DA, Miyashita EM, Khan G. Epstein-Barr virus and the B cell: that´s all it takes. Trends Microbiol 1996; 4: 204-208.
  29. Weiss LM, Chang KL. Association of the Epstein-Barr virus with hematolymphoid neoplasia. Adv Anatomic Pathol 1996; 3: 1-15.

[INDICE] [GENERALIDADES] [DETECCIÓN DEL VEB EN LOS TEJIDOS]
[VEB Y TUMORES EPITELIALES] [VEB Y NEOPLASIAS LINFOIDES]

 

Siguiente Conferencia »